mTOR inhibition enhances efficacy of dasatinib in ABL-rearranged Ph-like B-ALL

Published 2018 View Full Article

  1. Home
  2. Publications
  3. Publication Search
  4. Publication Details
Title
mTOR inhibition enhances efficacy of dasatinib in ABL-rearranged Ph-like B-ALL
Authors
Keywords
acute leukemia; animal model; childhood leukemia; leukemia therapy; tyrosine kinases
Journal
Oncotarget
Volume 9, Issue 5, Pages -
Publisher
Impact Journals, LLC
Online
2018-01-07
DOI
10.18632/oncotarget.24020

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Reprint

Contact the author

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started
Webinars Posters Questions Hubs Funding Journals Articles Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.